361 related articles for article (PubMed ID: 2797067)
21. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis and course of renal disease in IDDM/NIDDM: differences and similarities.
Ritz E; Keller C; Bergis K; Strojek K
Am J Hypertens; 1997 Sep; 10(9 Pt 2):202S-207S. PubMed ID: 9324123
[TBL] [Abstract][Full Text] [Related]
23. Early infant diet and risk of IDDM in blacks and whites. A matched case-control study.
Kostraba JN; Dorman JS; LaPorte RE; Scott FW; Steenkiste AR; Gloninger M; Drash AL
Diabetes Care; 1992 May; 15(5):626-31. PubMed ID: 1516481
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe.
Raine AE
Diabetologia; 1993 Oct; 36(10):1099-104. PubMed ID: 8243861
[TBL] [Abstract][Full Text] [Related]
25. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
[TBL] [Abstract][Full Text] [Related]
26. [Arterial hypertension as a risk factor in the cardiovascular complications of diabetes mellitus].
Feldstein CA; Arpa A
Rev Clin Esp; 1992 Mar; 190(5):243-8. PubMed ID: 1579695
[TBL] [Abstract][Full Text] [Related]
27. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
[TBL] [Abstract][Full Text] [Related]
28. Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands.
Chandie Shaw PK; Vandenbroucke JP; Tjandra YI; Rosendaal FR; Rosman JB; Geerlings W; de Charro FT; van Es LA
Diabetologia; 2002 Mar; 45(3):337-41. PubMed ID: 11914738
[TBL] [Abstract][Full Text] [Related]
29. Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation.
Freedman BI; Espeland MA; Heise ER; Evans J; Canzanello VJ
J Am Soc Nephrol; 1993 Feb; 3(8):1467-73. PubMed ID: 8490118
[TBL] [Abstract][Full Text] [Related]
30. Physician and patient prevention practices in NIDDM in a large urban managed-care organization.
Martin TL; Selby JV; Zhang D
Diabetes Care; 1995 Aug; 18(8):1124-32. PubMed ID: 7587847
[TBL] [Abstract][Full Text] [Related]
31. Diabetic renal disease in Pima Indians.
Nelson RG; Bennett PH
Transplant Proc; 1989 Dec; 21(6):3913-5. PubMed ID: 2609404
[TBL] [Abstract][Full Text] [Related]
32. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.
Nelson RG; Newman JM; Knowler WC; Sievers ML; Kunzelman CL; Pettitt DJ; Moffett CD; Teutsch SM; Bennett PH
Diabetologia; 1988 Oct; 31(10):730-6. PubMed ID: 3240833
[TBL] [Abstract][Full Text] [Related]
33. Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States.
Cowie CC; Harris MI; Silverman RE; Johnson EW; Rust KF
Am J Epidemiol; 1993 Apr; 137(7):719-32. PubMed ID: 8484363
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories.
Cordonnier DJ; Zmirou D; Benhamou PY; Halimi S; Ledoux F; Guiserix J
Diabetologia; 1993 Oct; 36(10):1109-12. PubMed ID: 8243863
[TBL] [Abstract][Full Text] [Related]
35. Retinopathy as a predictor of other diabetic complications.
El-Asrar AM; Al-Rubeaan KA; Al-Amro SA; Moharram OA; Kangave D
Int Ophthalmol; 2001; 24(1):1-11. PubMed ID: 11998880
[TBL] [Abstract][Full Text] [Related]
36. Diabetic nephropathy and end-stage renal failure: the Norwegian story.
Bergrem H; Leivestad T
Adv Ren Replace Ther; 2001 Jan; 8(1):4-12. PubMed ID: 11172323
[TBL] [Abstract][Full Text] [Related]
37. Treatment of end-stage renal failure due to diabetes in the United Kingdom.
Cameron JS
J Diabetes Complications; 1992; 6(1):1-6. PubMed ID: 1562752
[No Abstract] [Full Text] [Related]
38. Epidemiology of end-stage renal disease in patients with diabetes mellitus: from the dark ages to the middle ages.
Catalano C; Marshall SM
Nephrol Dial Transplant; 1992; 7(3):181-90. PubMed ID: 1314987
[No Abstract] [Full Text] [Related]
39. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients.
Feleke Y; Abdulkadir J; Aderaye G
East Afr Med J; 1999 Jul; 76(7):361-4. PubMed ID: 10520361
[TBL] [Abstract][Full Text] [Related]
40. Diabetes mellitus and renal replacement therapy in Italy: prevalence, main characteristics and complications.
Catalano C; Postorino M; Kelly PJ; Fabrizi F; Enia G; Goodship TH; Fulcher GR; Maggiore Q
Nephrol Dial Transplant; 1990; 5(9):788-96. PubMed ID: 2129352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
